Clariane SE (LON:0OPS)
London · Delayed Price · Currency is GBP · Price in EUR 3.938
-0.051 (-1.28%)
At close: Feb 11, 2026
Clariane SE Market Cap
Clariane SE has a market cap or net worth of 1.23 billion as of February 12, 2026. Its market cap has increased by 84.92% in one year.
Market Cap
1.23B
Enterprise Value
8.02B
Revenue
4.55B
Ranking
n/a
PE Ratio
n/a
Stock Price
3.94
Market Cap Chart
Since November 24, 2006, Clariane SE's market cap has increased from 527.71M to 1.23B, an increase of 133.77%. That is a compound annual growth rate of 4.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.22B | -0.06% |
| Dec 31, 2025 | 1.22B | 99.19% |
| Dec 31, 2024 | 614.59M | 175.90% |
| Dec 29, 2023 | 222.76M | -76.49% |
| Dec 30, 2022 | 947.41M | -61.61% |
| Dec 31, 2021 | 2.47B | -16.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.40B |
| GSK plc | 86.64B |
| Haleon | 34.95B |
| Smith & Nephew | 10.82B |
| Genus | 2.04B |
| HUTCHMED (China) | 1.82B |
| Oxford Nanopore Technologies | 1.36B |
| Oxford Biomedica | 1.00B |